Skip to main content
SpringerLink
Log in

Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous Ovarian Adenocarcinoma

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We analyzed the peculiarities of the copy number variation of genes that regulate apoptosis, DNA repair, cell proliferation, metabolism, and estrogen reception in tumor and normal cells of high-grade and low-grade serous adenocarcinoma of the ovaries. Using real-time qPCR method, the relative copy number of 34 genes (BAX, BCL2, TP53, MDM2, CASP9, CASP3, CASP7, CASP8, PRKCI, SOX2, OCT4, PIK3, PTEN, C-MYC, SOX18, AKT1, NOTCH1, BRCA1, BRCA2, EXO1, SCNN1A, KRAS, EGFR, BRAF, CYP1A1, CYP1A2, CYP1B1, CYP19A, ESR1, ESR2, GPER, STS, SULT1A, and SULT1E1) was determined in normal and tumor cells of the ovaries extracted by contactless capture laser microsection from FFPE-blocks of 200 patients. The most typical molecular markers of ovarian serous adenocarcinoma cells were identified: copy number of PIK3CA, BCL2, BAX, CASP3, and CASP8 genes. Based on the differences in the gene copy number variation, two molecular subtypes of serous adenocarcinoma were identified, corresponding to two histological subtypes: high-grade (MDM2, SOX2, ESR1, CYP1B1, SULT1E1, TP53, BRCA2) and low-grade (PIK3CA, PTEN, BCL2, BAX, and CASP3). Each of these subtypes was also characterized by molecular heterogeneity and can be subdivided into several subgroups: 3 subgroups for high-grade and 4 subgroups for low-grade serous adenocarcinoma. These findings extend our understanding of the molecular mechanisms of carcinogenesis in the ovarian tissue, confirm molecular difference between the two histological subtypes of serous adenocarcinoma probably underlying their different clinical course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kolesnikov EN, Maksimov AYu, Kit OI, Kutilin DS. Dependence of overall and relapse-free patients survival from molecular genetic subtype of esophageal squamous cell cancer. Vopr. Onkol. 2019;65(5):691-700. Russian.

    Google Scholar 

  2. Kutilin DS, Airapetova TG, Anistratov PA, Pyltsin SP, Leiman IA, Karnaukhov NS, Kit OI. Copy Number Variation in Tumor Cells and Extracellular DNA in Patients with Lung Adenocarcinoma. Bull. Exp. Biol. Med. 2019;167(6):771-778. https://doi.org/10.1007/s10517-019-04620-y

    Article  CAS  PubMed  Google Scholar 

  3. Kutilin DS, Dimitriadi SN, Vodolazhsky DI, Frantsiyants HM, Kit OI. Effect of thermal ischemia-reperfusion on expression of apoptosis-regulating genes in the renal tissue of patients with renal cell carcinoma. Nefrologiya. 2017;21(1):80-86. Russian.

    Google Scholar 

  4. Tsandekova MR, Porkhanova NV, Kutilin DS. Molecular characteristic of serous ovarian adenocarcinoma: implications for diagnosis and treatment. Sovremen. Probl. Nauki Obrazovania. 2020;(1):55. Russian.

  5. Beltrame L, Di Marino M, Fruscio R, Calura E, Chapman B, Clivio L, Sina F, Mele C, Iatropoulos P, Grassi T, Fotia V, Romualdi C, Martini P, Noris M, Paracchini L, Craparotta I, Petrillo M, Milani R, Perego P, Ravaggi A, Zambelli A, Ronchetti E, D’Incalci M, Marchini S. Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study. Ann. Oncol. 2015;26(7):1363-1371.

    Article  CAS  Google Scholar 

  6. Blagden SP. Harnessing pandemonium: the clinical implications of tumor heterogeneity in ovarian cancer. Front. Oncol. 2015;5:149. https://doi.org/10.3389/fonc.2015.00149

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bouska A, Eischen CM. Mdm2 affects genome stability independent of p53. Cancer Res. 2009;69(5):1697-1701.

    Article  CAS  Google Scholar 

  8. Gajjar K, Martin-Hirsch PL, Martin FL. CYP1B1 and hormone-induced cancer. Cancer Lett. 2012;324(1):13-30.

    Article  CAS  Google Scholar 

  9. He J, Chang W, Feng C, Cui M, Xu T. Endometriosis malignant transformation: epigenetics as a probable mechanism in ovarian tumorigenesis. Int. J. Genomics. 2018;2018:1465348. https://doi.org/10.1155/2018/1465348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol. Reprod. 2001;54(2):287-293.

    Article  Google Scholar 

  11. Krishnan A, Zhang R, Yao V, Theesfeld CL, Wong AK, Tadych A, Volfovsky N, Packer A, Lash A, Troyanskaya OG. Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nat. Neurosci. 2016;19(11):1454-1462.

    Article  CAS  Google Scholar 

  12. Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann. Oncol. 2013;24(Suppl. 10):x16-x21.

    Article  Google Scholar 

  13. Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded. Am. J. Pathol. 2016;186(4):733-747.

    Article  Google Scholar 

  14. Wang JYJ. Cell death response to DNA damage. Yale J. Biol. Med. 2019;92(4):771-779.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Medical Research Oncology Center, Ministry of Health of the Russian Federation, Rostov-on-Don, Russia

    D. S. Kutilin, M. R. Tsandekova & N. V. Porkhanova

Authors
  1. D. S. Kutilin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. R. Tsandekova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. V. Porkhanova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. S. Kutilin.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 170, No. 9, pp. 325-333, September, 2020

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kutilin, D.S., Tsandekova, M.R. & Porkhanova, N.V. Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous Ovarian Adenocarcinoma. Bull Exp Biol Med 170, 332–339 (2021). https://doi.org/10.1007/s10517-021-05062-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-021-05062-1

Key Words

Search

Navigation